Texas IRB shut down for significant violations of 21 CFR 56
In a warning letter dated September 24, 2012, FDA says the Texas Applied Biomedical Services Research Review Committee (TABS RRC) “significantly violated…21 CFR Part 56”. The agency is withholding approval of…